Indaptus Therapeutics Inc.(INDP:US)
Market Cap$322.74M
Key Metrics
Price$2.85
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$18.86M
EBITDA (TTM)-$17.42M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$1.5M
Total Assets$2.18M
Net Assets$1.25M
Total Debt$0
Key Metrics
Price$2.85
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$18.86M
EBITDA (TTM)-$17.42M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$1.5M
Total Assets$2.18M
Net Assets$1.25M
Total Debt$0
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $2.16M | $8.16M | $2.65M | $4.46M | - | - | - | - | - | - | - | $3.5M | $4.46M | $4.09M | $3.55M | $3.87M | $3.4M | $3.22M | $3.37M | $528.65K | $613.98K | $768.55K | $1.55M | $2.91M | |
| Research and Development | $491.13K | $2.85M | $1.52M | $2.17M | - | - | - | - | - | - | - | $1.48M | $1.88M | $1.91M | $1.61M | $1.51M | $1.3M | $944.64K | $697.67K | $391.12K | $489.72K | $352.13K | $1.35M | $1.28M |
| Selling, General, and Administrative | $1.67M | $5.31M | $1.13M | $2.29M | - | - | - | - | - | - | - | $2.01M | $2.58M | $2.18M | $1.94M | $2.36M | $2.1M | $2.27M | $2.67M | $137.53K | $124.25K | $416.42K | $196.58K | $1.63M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$2.16M | -$8.16M | -$2.65M | -$4.46M | - | - | - | - | - | - | - | -$3.5M | -$4.46M | -$4.09M | -$3.55M | -$3.87M | -$3.4M | -$3.22M | -$3.37M | -$528.65K | -$613.98K | -$768.55K | -$1.55M | -$2.91M |
| -$381.48K | $43.25K | -$326.63K | -$772.16K | $40.13K | $40.52K | $73.02K | $93.62K | $136.56K | $176.85K | $326.02K | $250.2K | $201.93K | - | $86.18K | $33.76K | $36.92K | - | $1.65K | $13.17K | $1.55K | - | $7.36K | - | |
| Non-Operating Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $827 | - | - | - | $3.68K | - |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | -$381.48K | $43.25K | -$326.63K | -$772.16K | $40.13K | $40.52K | $73.02K | $93.62K | $136.56K | $176.85K | $326.02K | $250.2K | $201.93K | - | $86.18K | $33.76K | $36.92K | - | $827 | $13.17K | $1.55K | - | $3.68K | - |
Income Before Tax | -$2.54M | -$8.11M | -$2.98M | -$5.23M | - | - | - | - | - | - | - | -$3.25M | -$4.25M | -$3.66M | -$3.47M | -$3.84M | -$3.37M | -$3.22M | -$3.37M | -$515.48K | -$612.42K | -$770.22K | -$1.54M | -$2.9M |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $13K | - | - | - | $46K |
Net Income | -$2.54M | -$8.11M | -$2.98M | -$5.23M | - | - | - | - | - | - | - | -$3.25M | -$4.25M | -$3.66M | -$3.47M | -$3.84M | -$3.37M | -$3.22M | -$3.37M | -$515.48K | -$612.42K | -$770.22K | -$1.54M | -$2.95M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$2.54M | -$8.11M | -$2.98M | -$5.23M | - | - | - | - | - | - | - | -$3.25M | -$4.25M | -$3.66M | -$3.47M | -$3.84M | -$3.37M | -$3.22M | -$3.37M | -$515.48K | -$612.42K | -$770.22K | -$1.54M | -$2.95M |
Shares Outstanding (Basic) | 10.96M | - | 997.04K | 574.92K | 503.66K | - | 339.66K | 8.54M | 8.44M | - | 8.4M | 8.4M | 8.4M | - | 8.26M | 8.26M | 8.26M | - | 4.18M | 5.41M | 5.41M | - | 5.41M | 5.41M |
Shares Outstanding (Diluted) | 10.96M | - | 997.04K | 574.92K | 503.66K | - | 339.66K | 8.54M | 8.44M | - | 8.4M | 8.4M | 8.4M | - | 8.26M | 8.26M | 8.26M | - | 4.18M | 5.41M | 5.41M | - | 5.41M | 5.41M |
EPS (Basic) | -$0.23 | - | -$2.98 | -$9.09 | -$8.96 | - | -$8.96 | -$0.47 | -$0.45 | - | -$0.47 | -$0.39 | -$0.51 | - | -$0.42 | -$0.46 | -$0.41 | - | -$0.81 | -$0.095 | -$0.11 | - | -$0.29 | -$0.55 |
EPS (Diluted) | -$0.23 | - | -$2.98 | -$9.09 | -$8.96 | - | -$8.96 | -$0.47 | -$0.45 | - | -$0.47 | -$0.39 | -$0.51 | - | -$0.42 | -$0.46 | -$0.41 | - | -$0.81 | -$0.095 | -$0.11 | - | -$0.29 | -$0.55 |
EBIT | -$2.16M | -$8.16M | -$2.65M | -$4.46M | - | - | - | - | - | - | - | -$3.5M | -$4.46M | -$4.09M | -$3.55M | -$3.87M | -$3.4M | -$3.22M | -$3.37M | -$528.65K | -$613.98K | -$768.55K | -$1.55M | -$2.91M |
EBITDA | -$2.16M | -$8.16M | -$2.65M | -$4.46M | - | - | - | - | - | - | - | -$3.49M | -$4.45M | -$4.09M | -$3.55M | -$3.87M | -$3.4M | -$3.22M | -$3.37M | -$528.43K | -$613.76K | -$768.34K | -$1.55M | -$2.91M |